Table 3.
Adjusted relative risks and 95% confidence intervals for the association between indicators and predicted probabilities of poor function with treatment or mortality.
| Treatment contrasta | One-year all- cause mortality (N=27,184)b |
||||
|---|---|---|---|---|---|
| N | Laparoscopic surg. (N=29,687) |
Chemotherapy (N=26,209) |
FOLFOX (N=7,594) |
||
| Chrischilles | |||||
| 0 indicators | 15,425 | 1.00 | 1.00 | 1.00 | 1.00 |
| 1 indicator | 8,275 | 1.04 (0.99, 1.08) | 0.97 (0.94, 0.99) | 0.99 (0.95, 1.04) | 1.18 (1.09, 1.28) |
| 2+ indicators | 5,987 | 0.89 (0.84, 0.94) | 0.87 (0.83, 0.91) | 0.92 (0.85, 0.99) | 1.45 (1.34, 1.58) |
| INDICATORS OF POOR FUNCTION | |||||
| Faurot | |||||
| 0 | 9,238 | 1.00 | 1.00 | 1.00 | 1.00 |
| 1 | 8,321 | 1.10 (1.05, 1.15) | 1.01 (0.99, 1.04) | 0.96 (0.92, 1.00) | 1.03 (0.94, 1.14) |
| 2+ | 12,128 | 0.99 (0.94, 1.04) | 0.90 (0.86, 0.93) | 0.93 (0.87, 0.98) | 1.42 (1.29, 1.57) |
| Davidoff | |||||
| 0 | 13,504 | 1.00 | 1.00 | 1.00 | 1.00 |
| 1 | 8,893 | 1.08 (1.04, 1.13) | 1.00 (0.98, 1.02) | 1.02 (0.97, 1.06) | 1.05 (0.97, 1.14) |
| 2+ | 7,290 | 1.03 (0.98, 1.09) | 0.95 (0.92, 0.99) | 0.86 (0.80, 0.92) | 1.25 (1.15, 1.36) |
| Segal | |||||
| 0–1 | 12,915 | 1.00 | 1.00 | 1.00 | 1.00 |
| 2 | 5,960 | 1.11 (1.06, 1.17) | 1.00 (0.97, 1.03) | 0.98 (0.93, 1.03) | 1.05 (0.95, 1.15) |
| 3+ | 10,812 | 1.01 (0.97, 1.06) | 0.97 (0.94, 1.00) | 0.96 (0.90, 1.01) | 1.21 (1.12, 1.32) |
| PREDICTED PROBABILITY OF POOR FUNCTION | |||||
| Faurot | |||||
| Lowest third | 9,859 | 1.00 | 1.00 | 1.00 | 1.00 |
| Middle third | 9,932 | 0.89 (0.85, 0.93) | 0.92 (0.90, 0.94) | 0.89 (0.85, 0.93) | 1.53 (1.38, 1.69) |
| Highest third | 9,896 | 0.75 (0.71, 0.80) | 0.64 (0.60, 0.67) | 0.73 (0.67, 0.80) | 2.36 (2.12, 2.63) |
| Davidoff | |||||
| Lowest third | 9,896 | 1.00 | 1.00 | 1.00 | 1.00 |
| Middle third | 9,895 | 0.84 (0.80, 0.87) | 0.93 (0.91, 0.95) | 0.92 (0.88, 0.96) | 1.31 (1.20, 1.43) |
| Highest third | 9,896 | 0.71 (0.68, 0.75) | 0.81 (0.79, 0.84) | 0.85 (0.81, 0.90) | 1.73 (1.60, 1.88) |
| Segal | |||||
| Lowest third | 9,899 | 1.00 | 1.00 | 1.00 | |
| Middle third | 9,822 | 1.01 (0.96, 1.07) | 0.87 (0.84, 0.90) | 0.90 (0.85, 0.96) | 1.57 (1.41, 1.76) |
| Highest third | 9,966 | 0.95 (0.88, 1.02) | 0.66 (0.62, 0.71) | 0.61 (0.54, 0.68) | 2.04 (1.79, 2.33) |
a
Adjusted for stage, sex, age (<75, 75–84, 85+), race (White non-Hispanic, Black non-Hispanic, Hispanic, Other), and Gagne comorbidity score (continuous).
b
Adjusted for stage, sex, age (<75, 75–84, 85+), race (White non-Hispanic, Black non-Hispanic, Hispanic, Other), and Gagne comorbidity score (<0, 0, 1, 2, 3, 4+).